Healthy Lifestyle and Longevity (2026): The Evidence on Diet, Exercise, Supplements & Anti-Aging Drugs
By Dr. Frank Yap, MD | Medically reviewed by One Day MD Review Team | Originally published: August 24, 2026 | Last updated: September 29, 2026
- What the Best Evidence Shows
- Other Studies Point the Same Way
- How Much Does Each Lifestyle Factor Matter?
- What About Supplements?
- What About Anti-Aging Drugs?
- Drugs That Prevent Age-Related Disease
- Be Careful With "Years Added" Claims
- Evidence Hierarchy
- So, How Many Years Can Lifestyle Buy?
- Healthspan vs. Lifespan
- Preventing Falls and Injury
- The Biggest Longevity Return on Investment
- Genetics, Starting Late, and What We Don't Know
- Frequently Asked Questions
- Bottom Line
- References
The strongest evidence suggests the biggest gains come from a combination of healthy behaviors and control of major risk factors. However, the Harvard estimate was a prospective observational analysis combined with life-table modelling, not a randomized trial proving that each person will live exactly 12 to 14 years longer.
It is tempting to read longevity studies as a prescription for an extra number of years: exercise gives three, a Mediterranean diet gives four, a supplement gives two more. Human biology is not that simple. The better-supported conclusion is that healthy behaviors can substantially reduce the probability of premature death and chronic disease. The size of the benefit depends on age, genetics, smoking history, metabolic health, existing disease, socioeconomic circumstances, environment and consistency.
What Does the Best Evidence Actually Show?
The most cited analysis comes from Harvard T.H. Chan School of Public Health researchers using the Nurses' Health Study and Health Professionals Follow-up Study. They evaluated five lifestyle factors:
- Never smoking
- Healthy body mass index (18.5 to 24.9 kg/m² in the study)
- At least 30 minutes per day of moderate-to-vigorous physical activity
- A relatively high-quality diet
- Moderate alcohol consumption as defined by the study
At age 50, estimated additional life expectancy was about 43.1 years for women and 37.6 years for men with all five low-risk factors, versus about 29.0 and 25.5 years with none. That is a projected difference of roughly 14.0 years for women and 12.2 years for men. Li et al., Circulation (2018)
Important interpretation: "14 additional years" is a population-level comparison of groups with very different risk profiles. It does not mean that starting a healthy lifestyle at 50 guarantees 14 extra years.
Other Studies Point in the Same Direction
A Swedish prospective cohort of more than 64,000 adults found that four healthy behaviors (nonsmoking, regular physical activity, a healthier diet, lower-risk alcohol use) were each associated with lower all-cause mortality. People with all four had an estimated survival advantage of about 4 to 5 years versus those with none or one. Larsson et al., J Intern Med (2017)
A BMJ analysis examined years free from cancer, cardiovascular disease and type 2 diabetes. At 50, women with four or five low-risk factors had an estimated 34.4 disease-free years versus 23.7 with none. For men, the figures were 31.1 versus 23.5. BMJ
The potential benefit is not simply living longer, but spending more of those years without major chronic disease.
How Much Does Each Lifestyle Factor Matter?
1. Not Smoking Is Probably One of the Biggest Wins
Smoking is one of the strongest modifiable causes of premature death, and the evidence is enormous. Quitting helps even after years of smoking, so the goal is to eliminate tobacco exposure as early as possible. For a smoker, cessation likely produces a much larger longevity benefit than any exotic supplement.
2. Exercise Has Strong Evidence
The World Health Organization recommends adults get about 150 to 300 minutes per week of moderate-intensity aerobic activity, or 75 to 150 minutes of vigorous activity, or an equivalent mix, plus muscle-strengthening on at least two days per week. Some activity is better than none, and more brings additional benefit with diminishing returns. It does not have to mean a gym: walking, cycling, swimming, sport and physically demanding daily activity all count.
3. Diet Matters, but There Is No Single "Longevity Diet"
Healthy dietary patterns are consistently associated with lower risks of cardiovascular disease, diabetes and premature mortality. Mediterranean-style and other minimally processed, plant-forward patterns emphasize:
- Vegetables and fruits
- Legumes
- Whole grains
- Nuts and seeds
- Fish and other healthy protein sources
- Unsaturated fats such as olive oil
- Minimal ultra-processed foods
- Less processed meat and added sugar
No diet has magical anti-aging properties. Healthier patterns improve several risk pathways at once, including blood pressure, lipids, glucose regulation, body weight and cardiovascular risk. A high-quality diet combined with activity and no tobacco matters more than obsessing over one "superfood."
4. Healthy Weight Helps, but BMI Is Not the Whole Story
BMI does not distinguish muscle from fat, show where fat is distributed, or capture metabolic health. For longevity, consider the broader picture: waist circumference, blood pressure, blood glucose and insulin resistance, lipids, fitness, muscle mass and strength, and overall diet quality. The objective is metabolic and functional health, not a particular number on a scale.
5. Alcohol Is Not a Longevity Supplement
Older observational studies sometimes found lower cardiovascular mortality among moderate drinkers, but that evidence is hard to interpret because of confounding and differences between drinkers and nondrinkers. Nobody should start drinking to extend life, and people who drink generally reduce harm by drinking less. Do not turn "moderate alcohol" into a longevity prescription.
What About Supplements?
Here the evidence is much less impressive. Supplements can help when they correct a deficiency, meet a specific requirement or are prescribed for a medical indication. But evidence that they substantially extend lifespan in otherwise healthy people is far weaker than for smoking cessation, activity and diet quality.
The U.S. Preventive Services Task Force concluded that:
- There is insufficient evidence to say whether multivitamins prevent cardiovascular disease or cancer.
- There is insufficient evidence for most individual vitamin or mineral supplements for these outcomes.
- Vitamin E is not recommended for preventing cardiovascular disease or cancer.
- Beta-carotene is not recommended for this purpose and may increase lung cancer risk in people at increased risk, including smokers.
The underlying systematic review covered 84 studies and about 739,803 participants and found little or no benefit for preventing cancer, cardiovascular disease and death, with some evidence of a small reduction in cancer incidence with multivitamins.
Practical conclusion: supplements are a secondary strategy, not a substitute for diet, exercise, smoking cessation, sleep, preventive care and control of cardiovascular and metabolic risk.
Can Vitamin D, Omega-3, Curcumin, NMN or Others Add Years?
There is no high-quality human evidence that a particular supplement reliably adds a specific number of years. A supplement may improve a biomarker, correct a deficiency, improve a physiological function, reduce risk of a specific condition in a defined group, or look promising in animals and laboratory studies. None of that automatically demonstrates longer human lifespan. For NMN, NAD precursors, spermidine, urolithin A, curcumin and similar agents, human research is far less mature than for conventional lifestyle interventions. It is inappropriate to add hypothetical supplement benefits together and promise "20 extra years."
Vitamin D Is More Complicated
An older meta-analysis of 18 randomized trials with 57,311 people found a modest reduction in all-cause mortality with vitamin D (RR 0.93, 95% CI 0.87 to 0.99) (PubMed). Later evidence has been less definitive, including a systematic review of 80 randomized trials and more than 163,000 participants (PubMed).
Correcting deficiency ≠ taking more vitamin D = living longer. Someone who is deficient may benefit substantially from correction, but that does not show that pushing levels above normal adds longevity.
What About Anti-Aging Drugs?
If lifestyle is the foundation, the next frontier is geroscience: using drugs to target biological processes that drive aging itself, rather than treating cancer, heart disease, diabetes and dementia one by one. Candidates include rapamycin and other mTOR inhibitors, metformin, senolytics and other compounds. These are promising for extending healthspan, but no drug has yet been conclusively proven in randomized human trials to extend the lifespan of otherwise healthy people by a specific number of years.
Rapamycin: One of the Most Interesting Candidates
Rapamycin (sirolimus) inhibits mTOR, a regulator of nutrient sensing, cell growth, protein synthesis and autophagy. In laboratory animals it can substantially extend lifespan, even when started late in life. Animal results cannot simply be converted into human life-expectancy gains.
A 2024 systematic review of 19 human studies found rapamycin or rapalogs improved some aging-related physiological parameters, particularly immune, cardiovascular and skin-related, but not endocrine, muscular or neurological ones. Long-term effects remain uncertain, and some studies reported more infections and adverse lipid changes in people with age-related disease (Lee et al., Lancet Healthy Longevity, 2024).
The 48-week PEARL randomized placebo-controlled trial of intermittent low-dose rapamycin in healthy adults gave useful safety and healthspan data but does not establish lifespan extension (PEARL, Aging, 2025). A 2025 clinical evidence review reached the same conclusion: compelling preclinical evidence, but no proven anti-aging therapy for healthy older adults.
Metformin: Anti-Aging Drug or Diabetes Drug?
Metformin is widely used for type 2 diabetes. Interest in longevity arose because observational studies linked it to lower rates of age-related disease and mortality in people with diabetes. Proposed mechanisms include effects on AMPK, insulin signaling, mitochondrial metabolism, inflammation, autophagy and nutrient sensing, but mechanisms do not prove it slows aging in healthy people.
The proposed Targeting Aging with Metformin (TAME) study was designed to test whether metformin delays multiple age-related diseases. Evidence from people with diabetes cannot be extrapolated automatically to healthy adults. Notably, a long-term NIH-supported Diabetes Prevention Program follow-up reported in 2026 found that lifestyle intervention significantly reduced the risk of developing multiple chronic conditions, whereas metformin did not significantly reduce multimorbidity versus placebo (NIH, June 2026).
Reality check: a drug can have an impressive mechanism, promising animal data and favorable observational associations without yet showing it extends healthy human lifespan.
Senolytics: Removing "Zombie" Cells
Senolytics aim to eliminate senescent cells, which stop dividing but stay metabolically active and release inflammatory signals. In animals, removing them has shown effects on healthspan and age-related disease. In humans the field is early. Open questions include which cells to remove, which drugs can do so selectively, what dosing is appropriate, and whether this improves human healthspan or lifespan. Senolytics are an experimental geroscience strategy, not an established treatment.
Other Candidates
- mTOR inhibitors: rapamycin and rapalogs
- AMPK-modulating drugs: metformin
- Senolytics: designed to remove senescent cells
- Autophagy-enhancing strategies: aimed at cellular recycling
- NAD-related interventions: cellular energy and redox biology
- Anti-inflammatory approaches: chronic low-grade inflammation
- Targeted metabolic interventions: insulin sensitivity and nutrient sensing
Some rest mainly on laboratory and animal work, while others have entered human trials, so the evidence varies dramatically.
Why Anti-Aging Drugs Differ From Supplements
A drug can be designed to manipulate a specific pathway at a pharmacologically active dose, which means greater potential efficacy and greater potential risk. mTOR inhibition affects immune function, metabolism and cell growth, which may help in some settings and harm in others. "More pathway inhibition" does not necessarily mean more longevity.
Could Drugs Eventually Add 5, 10 or 20 Years?
Possibly, but there is currently no reliable human evidence supporting a specific number of years. Human trials first ask: Is it safe? Does it improve physical or immune function? Does it reduce frailty? Improve metabolic health? Delay age-related disease? Improve validated healthspan measures? And ultimately, does it reduce disability or mortality?
Evidence Hierarchy: Lifestyle vs. Drugs
- Lifestyle fundamentals: strong evidence for reducing premature mortality and major chronic disease.
- Prescription treatment of established risk factors: strong evidence when appropriately indicated (hypertension, diabetes, dyslipidemia).
- Geroscience drugs such as rapamycin and metformin: biologically compelling and increasingly studied, but not proven to extend lifespan in healthy humans.
- Senolytics and other emerging gerotherapeutics: promising but experimental.
- Longevity supplements: evidence varies widely, with little to show any specific supplement extends human lifespan.
- Animal-only interventions: hypothesis-generating, not evidence of human lifespan extension.
In 2026, lifestyle remains the safest and best-supported longevity intervention for the general population. The emerging model is not "drug instead of lifestyle" but healthy lifestyle + precision prevention + effective risk-factor treatment + carefully validated geroscience therapies, the last of which remains experimental.
Drugs That Prevent Age-Related Disease
Many diseases that shorten life are driven by modifiable cardiovascular, metabolic and renal risk factors. A medication that substantially reduces one of these can increase health-adjusted life expectancy even if it does not touch the mechanisms of aging.
GLP-1 Receptor Agonists
GLP-1 drugs such as semaglutide have transformed obesity and type 2 diabetes treatment. In the SELECT trial, semaglutide reduced major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease without diabetes (NEJM, 2023). That matters for longevity because cardiovascular disease is a leading cause of death. Still, it is premature to call GLP-1 drugs "anti-aging drugs": a medication can prevent heart attacks, strokes or kidney disease without slowing biological aging.
SGLT2 Inhibitors
Empagliflozin and dapagliflozin, originally glucose-lowering drugs, have shown cardiovascular and kidney benefits in selected patients. EMPA-REG OUTCOME showed reduced cardiovascular death and heart-failure hospitalization with empagliflozin in type 2 diabetes with established cardiovascular disease (NEJM, 2015), and DAPA-CKD extended the evidence to chronic kidney disease. The longevity implication is indirect.
Other Preventive Medicines
- Statins: lower LDL cholesterol and reduce major cardiovascular events in appropriately selected patients.
- Antihypertensives: reduce stroke, heart failure and other complications of high blood pressure.
- Aspirin in selected populations: can reduce certain cardiovascular events in high-risk groups, but routine primary-prevention use is not appropriate for everyone because bleeding risk can outweigh benefit.
- Diabetes medications: reduce complications, with some newer classes offering cardiovascular or kidney benefits beyond glucose lowering.
- Osteoporosis medications: reduce fractures, an important cause of disability, loss of independence and excess mortality in older adults.
Preventing Disease Is Not the Same as Slowing Aging
Consider two hypothetical interventions. Intervention A slows a fundamental aging process and lowers the risk of many age-related diseases at once. Intervention B greatly reduces the chance of dying from one disease but does not change the rate of aging. Both could increase lifespan, but only A modifies aging itself. The boundary may blur over time, and clinical outcomes, not marketing terms, will decide where a drug belongs.
Three different longevity concepts:
- Disease prevention: reduce the probability of developing or dying from a specific disease.
- Healthspan extension: increase the years you stay physically and cognitively healthy.
- Biological aging modification: alter fundamental aging processes to delay multiple age-related diseases and potentially extend healthy lifespan.
To a patient, the distinction may seem academic: a prevented heart attack, stroke, kidney failure or fracture means more years of life and function. Scientifically, though, it should not be mistaken for evidence of slowed aging. The right questions are whether a drug reduces all-cause mortality and major age-related disease, delays disability, extends disease-free life expectancy, improves physical and cognitive function, modifies validated aging markers, and provides benefits beyond preventing one disease.
So, are GLP-1 drugs and SGLT2 inhibitors longevity drugs? Potentially relevant to longevity, yes. Proven anti-aging drugs, no. The same applies to statins, antihypertensives, selected aspirin use, diabetes drugs and osteoporosis treatments. Preventing disease is one of the most powerful, evidence-based ways modern medicine already extends healthy life.
Why You Should Be Careful With "Years Added to Life" Claims
Most lifestyle-longevity research is observational, so it can reveal consistent associations but cannot fully eliminate confounding. People who exercise regularly may also have higher incomes, better healthcare access, lower smoking rates, healthier diets, different sleep, different occupational exposures and stronger social networks. Statistical adjustment cannot guarantee that all confounding is removed.
There is also reverse causation: people developing serious illness may become less active or lose weight, so some association between inactivity or low weight and mortality may reflect pre-existing disease rather than the behavior.
Evidence Hierarchy: How Strong Is the Longevity Evidence?
| Tier | Evidence type | What it can and cannot tell us |
|---|---|---|
| 1 | Randomized controlled trials | Best for showing an intervention causes an outcome, but decades-long lifespan trials are rare and hard to run. |
| 2 | Systematic reviews and meta-analyses of high-quality trials | Stronger estimates of effects on cardiovascular events, diabetes, cancer and other outcomes when several RCTs exist. |
| 3 | Large prospective cohort studies | Valuable for long-term mortality, but associations do not prove causation. |
| 4 | Life-table and statistical modelling | Translates mortality differences into projected life expectancy. These are projections, not measurements for an individual. |
| 5 | Mechanistic, laboratory and animal research | Shows biological plausibility and generates hypotheses, but cannot establish human lifespan extension. |
| 6 | Testimonials, anecdotes, marketing claims | Can generate hypotheses but are very weak evidence. |
So, How Many Years Can a Healthy Lifestyle Really Buy?
The most defensible answer is a range. Large observational studies suggest the gap between a very unhealthy and a consistently healthy lifestyle can be several years and, in some populations and models, more than a decade. The Harvard analysis estimated about 12 to 14 additional projected years at age 50. Other cohorts produced smaller estimates, and studies of disease-free or disability-free years have sometimes found similarly large gaps in healthy life expectancy. The variation reflects different populations, lifestyle definitions, follow-up periods, methods and comparison groups.
The honest takeaway: healthy living does not "buy" a fixed number of years. It shifts the odds, often substantially, toward longer survival and more years free of major chronic disease.
Healthspan May Matter More Than Lifespan
Living to 95 is not necessarily better if the last 15 years are dominated by disability, cardiovascular disease, dementia or multiple chronic illnesses. Researchers therefore distinguish:
- Lifespan: how long you live.
- Healthspan: how long you remain relatively healthy and functional.
- Disease-free life expectancy: how long you live without specified major diseases.
- Disability-free life expectancy: how long you live without significant functional disability.
The BMJ study is notable because healthy behaviors were linked not only to longer life but to more years free from cancer, cardiovascular disease and type 2 diabetes.
Preventing Falls and Injury: The Longevity Factor Most Guides Skip
Lifestyle studies usually count deaths from heart disease, cancer and diabetes, but injury is a separate route by which healthy years are lost. In older adults, a single fall can turn a fully independent person into someone who needs help with daily activities. Fall prevention therefore belongs beside diet, exercise and smoking cessation in any honest discussion of healthspan.
Why Falls Matter for Lifespan and Healthspan
- Fractures: Hip fractures usually require surgery, and mortality in the following year is substantially elevated in older adults. Many survivors never regain their prior independence.
- Head injury: Falls are a leading cause of traumatic brain injury in older adults, with higher risk if you take blood thinners.
- Fear of falling: After a fall, many people move less, which weakens muscle and balance and raises the risk of the next fall.
- Osteoporosis: Weak bones turn an ordinary fall into a fracture, so bone health and fall prevention work together.
What the Evidence Supports
| Strategy | What research shows | Evidence tier |
|---|---|---|
| Balance and functional exercise (including Tai Chi) | Cochrane reviews of randomized trials find exercise lowers the rate of falls by roughly a fifth to a quarter in community-dwelling older adults. Programs that challenge balance and total 3+ hours per week appear most effective. | Tier 2 |
| Muscle-strengthening | Supports mobility and function, consistent with WHO advice for strength work on at least two days a week. | Tier 2 to 3 |
| Medication review (sedatives, sleep aids, some antidepressants, opioids, antipsychotics, and blood-pressure drugs causing dizziness on standing) | Fall-risk-increasing drugs are a consistent, modifiable risk factor in the CDC STEADI initiative and the 2022 World Guidelines for Falls Prevention. Deprescribing trial results are mixed, so change medicines only with a clinician. | Tier 3 |
| Vision care | Regular eye exams and timely cataract surgery reduce fall risk. New multifocal glasses can be a hazard on stairs and outdoors until you adapt. | Tier 2 to 3 |
| Home hazard assessment | Most effective when delivered by an occupational therapist to higher-risk people; less useful as a generic checklist for low-risk adults. | Tier 2 |
| Multifactorial programs | The large STRIDE randomized trial (NEJM, 2020) found no significant reduction in serious fall injuries versus usual care plus education, showing assessment alone is not enough without follow-through. | Tier 1 |
| Vitamin D supplements | The USPSTF recommends against vitamin D for fall prevention in community-dwelling older adults not known to be deficient. Correcting a true deficiency is still reasonable. | Tier 1 to 2 |
This matches the pattern throughout this article: the unglamorous fundamentals (movement, strength, sensible medication use) beat supplements for protecting healthy years.
A Practical Fall-Prevention Checklist
- Train balance and strength: several sessions a week of balance-challenging exercise (tandem stance, single-leg stands near a counter, sit-to-stand repetitions, Tai Chi) plus the strength work above. Progress gradually.
- Protect muscle mass, especially during rapid weight loss, including on GLP-1 medicines. See our guide on preventing muscle loss on GLP-1 drugs.
- Ask for a medication review yearly and whenever you start a drug that causes drowsiness or dizziness. Do not stop prescribed medicines on your own.
- Check eyes and feet: yearly eye exam, and supportive, non-slip, well-fitting shoes indoors and out. Avoid walking in socks or loose slippers.
- Make the home safer: good lighting, night lights on the route to the bathroom, grab bars and non-slip mats (wet tile floors are a common hazard), no loose rugs, clear stairs.
- Stand up slowly, and tell your doctor if you feel lightheaded on standing. It can reflect dehydration, medication effects or low blood pressure on standing.
- Keep bones strong: adequate calcium and protein, weight-bearing exercise, and bone-density screening when indicated. Discuss osteoporosis treatment if you have had a fragility fracture.
- Limit alcohol, which impairs balance and raises injury risk.
- Do not stop moving after a fall. Report falls to your doctor, because fear-driven inactivity increases future risk.
Resource: CDC STEADI (Stopping Elderly Accidents, Deaths & Injuries)
The Biggest Longevity "Return on Investment"
If the objective is maximizing healthy years rather than collecting supplements, prioritize the fundamentals:
- Do not smoke.
- Exercise regularly. Aim for 150 to 300 minutes of moderate activity weekly, plus strength and balance training to preserve muscle and prevent falls.
- Eat a predominantly minimally processed, plant-forward diet.
- Maintain a healthy metabolic profile and body composition.
- Keep blood pressure, glucose and lipids under control.
- Sleep adequately and consistently.
- Prevent falls and injury. Train balance, review medications, check vision and make the home safer.
- Maintain meaningful social relationships and cognitive activity.
- Limit alcohol rather than treating it as medicine.
- Use supplements selectively, when there is a plausible indication or deficiency.
- Use preventive healthcare and evidence-based screening appropriate to age and risk.
These interventions look ordinary, and that is the point. The strongest evidence does not come from a single molecule or "anti-aging stack" but from reducing the major causes of premature disease and death.
Genetics, Starting Late, and What We Still Do Not Know
What About Genetics?
Genetics influences lifespan and disease risk, but predisposition does not make lifestyle irrelevant. Lifestyle and inherited risk interact, and many major modifiable risk factors remain actionable whatever your genes. Think in terms of risk reduction, not guaranteed lifespan extension.
What About Starting Late?
Healthier behaviors remain associated with better outcomes even when adopted in middle and older age. Someone who quits smoking, becomes active and improves metabolic health may gain far more than someone who already does most of these things. Do not let the absence of a perfect lifestyle become an excuse for doing nothing.
What We Still Do Not Know
- How much can lifestyle extend maximum human lifespan?
- Which interventions slow biological aging itself?
- How much of the benefit comes from cardiovascular prevention versus other mechanisms?
- Can specific supplements meaningfully extend human lifespan?
- Can combinations of lifestyle interventions produce benefits beyond their individual effects?
- What is the optimal amount of exercise for different ages and health conditions?
- Can personalized interventions based on genetics, biomarkers and biological age substantially improve outcomes?
Claims that science has already answered these with precision should be treated skeptically.
Frequently Asked Questions
Can a healthy lifestyle add 10 years to your life?
Potentially, at the population level. A major Harvard analysis estimated about 12 additional years for men and 14 for women at age 50 comparing five low-risk factors with none. It was observational with life-table modelling, so it is not a guaranteed individual benefit.
What lifestyle change has the biggest effect on lifespan?
There is no universal ranking. Smoking cessation is especially powerful for smokers, while activity, diet, healthy body composition and cardiovascular risk control each lower disease and mortality risk.
Does exercise really extend life?
Regular physical activity is consistently associated with lower mortality and cardiovascular risk. WHO recommends 150 to 300 minutes of moderate or 75 to 150 minutes of vigorous activity weekly, plus muscle-strengthening on at least two days.
Can supplements extend lifespan?
There is no strong human evidence that a supplement reliably adds a specific number of years in healthy adults. Supplements can correct deficiencies or meet specific needs but are not equivalent to the lifestyle fundamentals.
Is a multivitamin proven to make you live longer?
No. The USPSTF found insufficient evidence that multivitamins prevent cardiovascular disease or cancer. Some trials suggest modest benefits for particular outcomes, which is not proof of meaningful lifespan extension.
Should I take vitamin D for longevity?
Vitamin D matters, particularly if you are deficient, but randomized evidence has not established that routine supplementation extends lifespan in generally healthy adults. Base supplementation on nutritional need and clinical context.
Is the Mediterranean diet a longevity diet?
It is strongly associated with cardiovascular and metabolic benefits and is well studied. It is more accurate to call it a well-supported healthy pattern than one with a guaranteed lifespan-extending effect.
Can you undo years of unhealthy living?
Some risks fall substantially after behavior change, particularly after quitting smoking and improving activity and metabolic health. Past exposures can leave lasting effects, so think of reducing future risk rather than erasing the past.
Is healthspan more important than lifespan?
For many people, yes. The goal of preventive medicine is not only to postpone death but to increase years lived with good physical, cognitive and functional health.
How can older adults prevent falls?
The best-supported approach is regular balance and strength training (including Tai Chi), combined with an annual medication review, vision checks, proper footwear and a hazard-proofed home. Vitamin D supplements do not prevent falls in people who are not deficient.
Do falls affect life expectancy?
They can. Serious fall injuries such as hip fractures and head injuries are associated with disability, loss of independence and higher mortality in older adults, which is why fall prevention protects healthspan as well as lifespan.
Bottom Line
The evidence does not support a formula such as "healthy diet = 5 years, exercise = 4 years, supplements = 2 years." Human longevity is too complex. But the overall evidence is remarkably consistent: not smoking, staying physically active, eating a high-quality diet, maintaining healthy metabolic function and avoiding major preventable risks can substantially improve the probability of living longer, and living more years in good health. The strongest studies suggest the gap between a very unhealthy and a very healthy lifestyle can reach roughly a decade or more of projected life expectancy in some populations.
Preventing falls and injury deserves a place on that list too: balance and strength training, sensible medication review and a safer home help protect the independence that a longer life is meant to provide. Supplements may have a role in correcting deficiencies, but they sit much lower in the evidence hierarchy than the fundamentals.
Selected Evidence & References
- Li Y, Pan A, Wang DD, et al. Impact of Healthy Lifestyle Factors on Life Expectancies in the US Population. Circulation. 2018;138:345–355. PubMed | Full text (PMC)
- Nyberg ST, et al. Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes. BMJ. 2020. BMJ
- Larsson SC, Kaluza J, Wolk A. Combined impact of healthy lifestyle factors on lifespan. J Intern Med. 2017. PubMed
- World Health Organization. Physical activity. WHO
- USPSTF. Vitamin, Mineral, and Multivitamin Supplementation to Prevent CVD and Cancer. 2022. USPSTF
- O'Connor EA, et al. Vitamin and Mineral Supplementation to Prevent CVD and Cancer: Systematic Review. USPSTF Evidence Summary
- Sherrington C, et al. Exercise for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2019.
- Bhasin S, et al. A Randomized Trial of a Multifactorial Strategy to Prevent Serious Fall Injuries (STRIDE). N Engl J Med. 2020;383:129–140.
- Montero-Odasso M, et al. World guidelines for falls prevention and management for older adults: a global initiative. Age Ageing. 2022.
- USPSTF. Falls Prevention in Community-Dwelling Older Adults: Interventions.
- CDC. STEADI. cdc.gov/steadi
- I-PREVENT Aging Protocol: Anti Aging Guide to Help People Prevent and Reverse Aging. 2026. OneDayMD
Related Guides
- Metabolic Health: The Root of Chronic Disease
- I-LONGEVITY Protocol: Anti Aging Guide (2026)
- GLP-1 Drugs and Long-Term Healthspan
- Rapamycin vs. Metformin vs. GLP-1 Drugs
- How to Prevent Muscle Loss on GLP-1 Drugs
- I-Prevent Cancer Protocol
- Best Natural Supplements for Dementia
- Top Peptide Protocols 2026
.png)
.png)
.png)
.png)
.jpg)
Comments